Medtronic Inc || Medtronic Neuromodulation || Medtronic Puerto Rico, Operations Co. || Medtronic Puerto Rico Operations Co., Villalba.

What is this?

Description

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NIDFSINVIMA
  • 4 Events

3 devices in the database

  • Model / Serial
  • Product Description
    To perform chronic infusion of drugs or liquids.
  • Model / Serial
    8637-20 and 8637-40, specific serials.
  • Product Description
    To perform chronic infusion of drugs or liquids.
  • Model / Serial
    8637-20 and 8637-40, specific serials.
  • Product Description
    To perform chronic infusion of drugs or liquids.

One manufacturer with a similar name

Learn more about the data here

  • Manufacturer Parent Company (2017)
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    NIDFSINVIMA